Deng Z et al. isolated astrocyte-derived CD63+ exosomes and demonstrated that these exosomes have the potential to reduce the toxicity of Aβ in vitro and clear Aβ plaques in AD mice [70]. Here, CD63 is linked to Alzheimer disease.